Admission to the hospital and being seen by a neurologist are factors associated with better quality care for people with a transient ischemic attack, also known as mini-stroke, according to new research led by scientists from the U.S. Department of Veterans Affairs, Regenstrief Institute, Purdue University, and Indiana University.
Read More

In the quest to develop more effective treatments for parasitic diseases like African sleeping sickness, Chagas disease and Leishmaniasis, scientists look for weaknesses in the organisms’ molecular machinery. These weaknesses can then be targeted with drug therapies designed to kill the parasites.
Read More

The structure of a transport complex used by bacteria to import aspartate has been mapped in unique detail by University of Groningen scientists.
Read More

If the immune system attacks its own body, it can often have devastating consequences: autoantibodies bind to the body’s structures, triggering functional disorders.
Read More

The viral infections of the upper respiratory tract are an important cause of morbidity and mortality worldwide and, among them, influenza is one of the most important ones, with severe cases ranging from three and five million cases, and between 290,000 and 650,000 deaths per year. This is why a proper supervision of the disease is crucial.
Read More

Researchers have developed a new, inexpensive technology that could save lives and money by routinely screening women for breast cancer without exposure to radiation.
Read More

Cancer cells are notorious for their genetic disarray. A tumor cell can contain an abundance of DNA mutations and most have the wrong number of chromosomes.
Read More

Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.
Read More

An array of tests that combines functional assessment with blood tests and brain scans promises more sensitive and objective estimation of brain degeneration in human veterans exposed to battlefield improvised explosive device (IED) blasts, according to research led by doctors at the Icahn School of Medicine at Mount Sinai and the James J. Peters VA Medical Center. The study was published in Molecular Psychiatry on Tuesday, February 25, and featured on the journal’s cover.
Read More

Neuroscientists at the University of South Florida have become the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.
Read More